Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • HelenaSC
    Member
    • Jun 2013
    • 21

    Chip and Input different sizes libraries (NEBNext ChIP-Seq Library)

    Hi all!

    I'm new here (and also in Chip-Seq!) and I would like share some questions with you.

    We are preparing Chip-seq libraries for MiSeq, using NEBNext Chip-seq Library Prep Master Mix Set for Ilumina following the protocol with some modifications in the size selection of adaptor ligated DNA using AMPure XP Beads (we found a similar protocol that worked better for our samples , in order to get rid of the adaptor dimers).

    After the amplification of the library by PCR, what we find is that the INPUT library has a correct size distribution but the CHIP library is different, having an important part of larger fragments, as you can see in the image I've attached here.

    Of course, both come from the same sonicated sample and both have been processed and amplified together, with the same cycle number of amplification...

    1. Any idea or explanation for this larger fragments( Maybe it's some issue related with the IP?)

    2. Anyone has experience on sequencing this kind of library with those larger framents or knows how it could affect the sequencing process)?

    Thanks a lot in advance!
    Attached Files
  • michaelftang
    Junior Member
    • Jun 2014
    • 1

    #2
    we have a similar problem, did you ever solve your problem?
    Thanks
    Michael

    Comment

    • Annac
      Junior Member
      • Aug 2014
      • 1

      #3
      Hi all,
      I'm quite new in the ChIP-seq world, but I'm trying to optimise Ion ChIP-seq Library and I had similar problems with the bioanalyzer patterns, first I though it was something about the running, but after reading some answers from different forums and doing some more optimizations I'm almost sure that there are some important issues in the Chromatin immunoprecipitation:
      1) you should have proper shearing of the Chromatin, so you should have the high concentration of DNA fragments between 100-200bp. That it's really important for the sequencing step.
      2) When we're immunoprecipitating, longer fragments have higher affinity to the antibodies (I read that it can be due to the presence of more epitopes) so, for this reason in the IP sample from HelenaSC has larger fragments. I've solved this fact increasing the concentration of the antibody, we should saturate the sample so shorter fragments have also antibody available for IP.

      I hope it helps,

      Thanks,

      Anna

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Yesterday, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...